# Tvardi Therapeutics, Inc.: filings

TVRD · Nasdaq · CIK 1346830 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tvrd.md) · [Financials](/companies/tvrd/financials.md) · [Filings](/companies/tvrd/filings.md) · [Insiders](/companies/tvrd/insiders.md)

## Reports and events: 220 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 360, 8-K 146, 10-Q 38, SC 13G/A 38, 3 37, SC 13G 18, CORRESP 16, S-8 14, 10-K 13, UPLOAD 12, DEF 14A 11, DEFA14A 11, 424B5 9, EFFECT 8, 425 6, SCHEDULE 13G 6, 4/A 5, S-3 5, 424B3 4, S-1/A 4, SEC STAFF LETTER 4, 8-K/A 3, ARS 3, CT ORDER 3, SCHEDULE 13G/A 3, 424B4 2, D 2, S-1 2, S-4/A 2, SCHEDULE 13D/A 2, 8-A12B 1, CERTNAS 1, DRS 1, POS AM 1, POS EX 1, PRE 14A 1, S-3/A 1, S-3ASR 1, S-4 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-14 | 07:10 ET | [10-Q](/filings/0001104659-26-096424.md) | Quarterly report, period 2026-06-30 | 0001104659-26-096424 |
| 2026-08-14 | 07:05 ET | [8-K](/filings/0001104659-26-096417.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-096417 |
| 2026-07-30 | 07:30 ET | [8-K](/filings/0001104659-26-088461.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-088461 |
| 2026-07-17 | 16:07 ET | [8-K](/filings/0001104659-26-084627.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-084627 |
| 2026-07-07 | 07:02 ET | [8-K](/filings/0001104659-26-080930.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-080930 |
| 2026-06-11 | 16:05 ET | [8-K](/filings/0001104659-26-072930.md) | 5.07 Shareholder vote results | 0001104659-26-072930 |
| 2026-05-08 | 07:10 ET | [10-Q](/filings/0001104659-26-057528.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057528 |
| 2026-05-08 | 07:05 ET | [8-K](/filings/0001104659-26-057524.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057524 |
| 2026-04-23 | 16:10 ET | [DEF 14A](/filings/0001104659-26-047695.md) | Proxy statement, period 2026-06-09 | 0001104659-26-047695 |
| 2026-03-31 | 16:10 ET | [10-K](/filings/0001104659-26-037729.md) | Annual report, period 2025-12-31 | 0001104659-26-037729 |
| 2026-03-31 | 16:09 ET | [8-K](/filings/0001104659-26-037724.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-037724 |
| 2026-03-06 | 16:01 ET | [8-K](/filings/0001104659-26-024676.md) | 8.01 Other events | 0001104659-26-024676 |
| 2026-01-16 | 06:04 ET | [8-K](/filings/0001104659-26-004273.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-004273 |
| 2025-12-18 | 17:21 ET | [8-K](/filings/0001104659-25-122615.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-122615 |
| 2025-11-19 | 06:44 ET | [8-K](/filings/0001104659-25-113901.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-113901 |
| 2025-11-13 | 16:14 ET | [8-K](/filings/0001104659-25-111310.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-111310 |
| 2025-11-13 | 16:10 ET | [10-Q](/filings/0001104659-25-111289.md) | Quarterly report, period 2025-09-30 | 0001104659-25-111289 |
| 2025-10-20 | 17:28 ET | [S-1/A](/filings/0001104659-25-100896.md) | Registration statement, amended | 0001104659-25-100896 |
| 2025-10-14 | 06:11 ET | [8-K](/filings/0001104659-25-098908.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-098908 |
| 2025-10-07 | 16:31 ET | [S-1/A](/filings/0001104659-25-097519.md) | Registration statement, amended | 0001104659-25-097519 |
| 2025-08-14 | 16:31 ET | [8-K](/filings/0001104659-25-078665.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-078665 |
| 2025-08-14 | 16:10 ET | [10-Q](/filings/0001558370-25-011562.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011562 |
| 2025-07-14 | 17:00 ET | [8-K](/filings/0001104659-25-067785.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-067785 |
| 2025-06-09 | 06:05 ET | [8-K](/filings/0001104659-25-057524.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-057524 |
| 2025-05-30 | 16:03 ET | [S-1](/filings/0001104659-25-054853.md) | Registration statement | 0001104659-25-054853 |
| 2025-05-27 | 08:09 ET | [8-K](/filings/0001104659-25-052733.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-052733 |
| 2025-05-13 | 16:26 ET | [8-K](/filings/0001104659-25-047856.md) | 2.02 Results of operations; 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-25-047856 |
| 2025-05-13 | 16:20 ET | [8-K/A](/filings/0001104659-25-047844.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-25-047844 |
| 2025-05-13 | 16:10 ET | [10-Q](/filings/0001558370-25-007575.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007575 |
| 2025-04-16 | 16:15 ET | [SCHEDULE 13D/A](/filings/0000950170-25-054743.md) | Ownership report, active investor, amended | 0000950170-25-054743 |
| 2025-04-15 | 16:06 ET | [8-K](/filings/0001104659-25-035121.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-035121 |
| 2025-04-11 | 16:16 ET | [8-K](/filings/0001104659-25-034220.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-034220 |
| 2025-04-01 | 16:30 ET | [8-K](/filings/0001104659-25-030583.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-030583 |
| 2025-03-24 | 16:30 ET | [8-K](/filings/0001104659-25-027233.md) | 8.01 Other events | 0001104659-25-027233 |
| 2025-03-11 | 16:10 ET | [10-K](/filings/0001558370-25-002705.md) | Annual report, period 2024-12-31 | 0001558370-25-002705 |
| 2025-01-21 | 08:50 ET | [8-K](/filings/0001104659-25-004747.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-004747 |
| 2025-01-17 | 16:43 ET | [8-K](/filings/0001104659-25-004517.md) | 8.01 Other events | 0001104659-25-004517 |
| 2024-12-30 | 16:01 ET | [8-K](/filings/0001104659-24-132481.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-132481 |
| 2024-12-20 | 16:05 ET | [8-K/A](/filings/0001104659-24-130803.md) | 9.01 Financial statements and exhibits | 0001104659-24-130803 |
| 2024-12-18 | 17:10 ET | [SCHEDULE 13D/A](/filings/0000950170-24-137983.md) | Ownership report, active investor, amended | 0000950170-24-137983 |
| 2024-12-18 | 07:23 ET | [8-K](/filings/0001104659-24-129596.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-129596 |
| 2024-11-22 | 16:09 ET | [8-K](/filings/0001104659-24-122099.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-24-122099 |
| 2024-11-14 | 16:10 ET | [10-Q](/filings/0001558370-24-015713.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015713 |
| 2024-10-30 | 16:21 ET | [SC 13D](/filings/0001193125-24-247585.md) | Ownership report, active investor | 0001193125-24-247585 |
| 2024-08-14 | 16:10 ET | [10-Q](/filings/0001558370-24-012231.md) | Quarterly report, period 2024-06-30 | 0001558370-24-012231 |
| 2024-08-01 | 16:15 ET | [8-K](/filings/0001104659-24-084911.md) | 3.01 Delisting notice | 0001104659-24-084911 |
| 2024-06-18 | 16:16 ET | [8-K](/filings/0001104659-24-072821.md) | 2.05 Exit or disposal costs | 0001104659-24-072821 |
| 2024-06-12 | 17:12 ET | [8-K](/filings/0001104659-24-070914.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-070914 |
| 2024-06-07 | 16:05 ET | [8-K](/filings/0001104659-24-069625.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-069625 |
| 2024-05-13 | 16:17 ET | [10-Q](/filings/0001558370-24-007964.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007964 |

Page 1 of 5. [Older](/companies/tvrd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.